Cancer patients test easier blood clot prevention pill
NCT ID NCT07189897
Summary
This study is testing if a pill (apixaban) is a safe and easier-to-use alternative to a daily injection (enoxaparin) for preventing dangerous blood clots after head and neck cancer surgery. It will enroll about 76 patients who are scheduled for surgery. The main goal is to see if patients find the pill more satisfying and easier to stick with than the daily shot, while also checking for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SUNY Upstate
RECRUITINGSyracuse, New York, 13210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.